Newsfile Corp
20 Jul 2026, 19:47 UTC · 12h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
GeneDx lowered its full-year revenue guidance from $540-$550 million to $475-$490 million. — A significant downward revision of annual revenue guidance typically triggers immediate negative sentiment and stock price devaluation.
-0.80GeneDx reported a $31.2 million impairment loss related to its acquisition of Fabric Genomics. — Impairment losses signal that a prior strategic acquisition failed to deliver the expected value, damaging management's credibility.
-0.60GeneDx's adjusted gross margin declined from 74% to 69% in the first quarter of fiscal year 2026. — Margin compression indicates decreasing profitability per unit of sale or rising operational costs.
-0.40Continue reading
6 related stories
Top 1 mover · tap to explore
A securities class action lawsuit has been filed against GeneDx alleging failure to disclose material information and federal securities law violations. — Legal challenges and fraud allegations create long-term overhang and potential for significant settlement costs.
Which stocks this story touches
The company is facing a securities class action lawsuit following a 49.2% stock price drop and missed financial guidance.
The company is mentioned in the context of a securities fraud class action arising from alleged anticompetitive agreements.
The company is mentioned in the context of a securities fraud class action resulting from erroneous financial statements and a 31% stock decline.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
8h ago
